SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-021749
Filing Date
2018-08-14
Accepted
2018-08-14 17:10:54
Documents
44
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q gnpx-10q_20180630.htm 10-Q 966331
2 EX-10.1 gnpx-ex101_59.htm EX-10.1 38406
3 EX-31.1 gnpx-ex311_6.htm EX-31.1 16432
4 EX-31.2 gnpx-ex312_7.htm EX-31.2 17945
5 EX-32.1 gnpx-ex321_8.htm EX-32.1 8672
  Complete submission text file 0001564590-18-021749.txt   3072512

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT gnpx-20180630.xml EX-101.INS 353682
7 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20180630.xsd EX-101.SCH 35398
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gnpx-20180630_cal.xml EX-101.CAL 22598
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20180630_def.xml EX-101.DEF 105484
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20180630_lab.xml EX-101.LAB 269352
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20180630_pre.xml EX-101.PRE 189884
Mailing Address 1701 TRINITY STREET SUITE 3.322 AUSTIN TX 78712
Business Address 1701 TRINITY STREET SUITE 3.322 AUSTIN TX 78712 512-708-0155
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

IRS No.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38244 | Film No.: 181018792
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1